Displaying items by tag: division of pulmonary allergy and critical care medicine
UAB was a lead site in the testing of Kalydeco, the first drug to target the underlying genetic causes of cystic fibrosis.
A UAB researcher has received a grant to study idiopathic pulmonary fibrosis.
An antibiotic can help reduce acute COPD attacks and improve quality of life, a new study shows.
Tagged under
Tagged under
UAB is the first in the state to offer new procedure that uses thermal energy to help keep airways flowing freely.
Tagged under